Levels of Serum Interleukin-6, Tumor Necrosis Factor-α, and Interferon-γin Patients with Tuberculous Spondylitis After AntiTuberculosis Drugs Therapy and Its Relationship to Clinical Changes

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2019, Vol 18, Issue 3

Abstract

Background: This study aims to monitor changes in IFN-γ, TNF-α and IL-6 serum levels in patients with tuberculous spondylitis during oral antituberculosis administration. Methods: With a observational prospective cohort study involving 27 patients with tuberculosis spondylitis treated at Saiful Anwar Hospital, Malang in January-December 2017, serum IFN-γ, TNF-α and IL-6 levels were measured by enzyme-linked immunosorbant assay (ELISA ) at the time prior to oral antituberculous therapy, and after 2 months of therapy. Assessed correlation relationship of cytokine levels change compared with clinical change after 2 months of anti tuberculosis drug therapy. The degree of pain was measured by VAS scores and neurologic deficits measured by Frankel score. Result: The mean TNF-α levels increased after 2 months of OAT therapy. Pearson correlation test showed insignificant results with negative correlation relationship between improvement of degree of pain with elevated levels of TNF-α (r=-0.106; p=0.598). Pearson correlation test showed insignificant results with a positive correlation relationship between neurological deficit improvement with elevated levels of TNF-α TNF-α (r=- 0.291; p=0.140). The mean IFN-γ and IL-6 levels decreased after 2 months of OAT therapy. Pearson correlation test showed significant result with positive correlation correlation between improvement of degree of pain with decrease level of IFN-γ (r=0.561; p = 0.002) and IL-6 (r=0.591; p=0.001). The Pearson correlation test showed significant results with a positive correlation relationship between neurologic deficit improvement IFN-γ (r=0.570; p=0.002) dan IL-6 (r=0.080; p=0.690). Conclusion: TNF-α levels tend to increase during therapy, but are not significant. IFN-γ and IL-6 levels decreased significantly during oral antituberculous therapy and may be considered for monitoring the success of therapy.

Authors and Affiliations

Bhrahmantya . , Tjuk Risantoso

Keywords

Related Articles

Jugular Foramen Tumor; Experience in Tertiary Care Center

Objective Jugular foramen tumour is a locally invasive, tumor, which grow slowly and causes various symptoms such as pulsatile tinnitus and lower cranial nerve palsy. Complete surgical resection is regarded as the ideal...

Atlanto-Axial Subluxation of the Cervical Spine As the Initial Presentation of Rheumatoid Arthritis : A Case Report

Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease affecting a significant percentage of the population. Rheumatoid arthritis synovitis affects mostly small hand and feet joints, although it may comprom...

Prospective study of results of inflatable nail in pathological femoral diaphyseal fractures due toinfection

Infected pathological fracture is always a great problem for the treating clinician. No definite treatment policy has been drafted yet. We have used inflatable self-locking nail in six cases of pathological fracture due...

Chest X Ray findings in New Sputum Positive Pulmonary Tuberculosis

Background: Tuberculosis remains a worldwide public health problem. The guidelines of RNTCP suggest sputum as the initial diagnostic test for Tuberculosis. If sputum test is positive in patients who are receiving Anti tu...

Nonvital Tooth Bleaching, Noninvasive Technique: A Case Report

Discoloration of the tooth, especially the anterior, can result of considerably cosmetic impairment in young patients. To treat such kind of patient is a challenge for the dental practitioners. The variety of post endodo...

Download PDF file
  • EP ID EP557569
  • DOI 10.9790/0853-1803134752.
  • Views 72
  • Downloads 0

How To Cite

Bhrahmantya . , Tjuk Risantoso (2019). Levels of Serum Interleukin-6, Tumor Necrosis Factor-α, and Interferon-γin Patients with Tuberculous Spondylitis After AntiTuberculosis Drugs Therapy and Its Relationship to Clinical Changes. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 18(3), 47-52. https://europub.co.uk/articles/-A-557569